Manish Sahai Aggarwal, MD
Psychiatry · Folsom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sacramento Neuropsych Associates Inc · 8 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Aggarwal’s office at (916) 473-2235 to ask if they take your plan before you enroll.
California Medical Board record
Licence A133513 · Current
Licensed to practise in California · since 2014 · expires 2028-02-29 · Baba Farid University of Health Sciences Dayanand Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$49,469
Medicare paid this office $49,469 for 18 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
18 Original Medicare patients in 2024. Average age 64 · Health risk score 1.02. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75%.
The office billed $97,209, Medicare allowed $62,362 and paid $49,469; for 343 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 18 | 343 | 64 | 1.02 | $97,209 | $49,469 |
| 2018 | 12 | 136 | 60 | 1.06 | $32,829 | $10,676 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2018: 1 service
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $2,382 | $53 |
Medicaid work
$4,483 in 2024
Medicaid paid $4,483 for 51 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 25 | $2,885 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 26 | $1,598 |
| 2024 | 51 | 2 | 23 | $4,483 |
Drugs they prescribed that Part D paid
$33,710
Pharmacies billed $33,710 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 232) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
204 generic and 28 brand-name prescriptions · $33,710 in drug cost · 16 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Spravato | 22 | $27,643 | $1,257 |
| Desvenlafaxine Succinate Er | 14 | $1,358 | $97 |
| Trazodone | 40 | $236 | $6 |
| Dextroamphetamine-Amphet Er | 13 | $177 | $14 |
| Escitalopram | 13 | $139 | $11 |
See all 8 drugs
| Spravato | 22 | $27,643 | $1,257 |
| Desvenlafaxine Succinate Er | 14 | $1,358 | $97 |
| Trazodone | 40 | $236 | $6 |
| Dextroamphetamine-Amphet Er | 13 | $177 | $14 |
| Escitalopram | 13 | $139 | $11 |
| Gabapentin | 11 | $123 | $11 |
| Clonazepam | 16 | $52 | $3 |
| Venlafaxine Hcl Er | 15 | $6 | $0 |
Year by year
| 2024 | 232 | 32 | 0% (0) | 12% | $33,710 |
| 2023 | 182 | 29 | 0% (0) | None | $12,772 |
| 2022 | 137 | 17 | 0% (0) | None | $3,160 |
| 2021 | 121 | 13 | 0% (0) | None | $2,599 |
| 2020 | 175 | 12 | 0% (0) | None | $3,980 |
| 2019 | 203 | 26 | 0% (0) | 9% | $15,739 |
| 2018 | 103 | 20 | 0% (0) | None | $3,494 |
| 2017 | 39 | None | None | None | $2,571 |
| 2016 | 11 | None | 0% (0) | 0% | $157 |
| 2014 | 11 | None | 0% (0) | 0% | $218 |
| 2013 | 32 | None | 0% (0) | 47% | $12,287 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Desvenlafaxine Succinate Er | 20 | $1,800 | $90 |
| Gabapentin | 16 | $316 | $20 |
| Trazodone | 23 | $149 | $6 |
| Venlafaxine Hcl Er | 13 | $128 | $10 |
| Quetiapine | 12 | $115 | $10 |
| Fluoxetine | 15 | $102 | $7 |
| Clonazepam | 16 | $65 | $4 |
2022: 3 drugs
| Buspirone | 18 | $289 | $16 |
| Gabapentin | 17 | $184 | $11 |
| Trazodone | 14 | $77 | $6 |
2021: 5 drugs
| Aripiprazole | 11 | $456 | $41 |
| Buspirone | 15 | $235 | $16 |
| Trazodone | 17 | $119 | $7 |
| Escitalopram | 12 | $115 | $10 |
| Lorazepam | 12 | $21 | $2 |
2020: 6 drugs
| Venlafaxine Hcl Er | 22 | $803 | $37 |
| Bupropion Hcl Sr | 11 | $463 | $42 |
| Aripiprazole | 11 | $321 | $29 |
| Gabapentin | 23 | $242 | $11 |
| Trazodone | 21 | $96 | $5 |
| Lorazepam | 19 | $48 | $3 |
2019: 5 drugs
| Venlafaxine Hcl Er | 19 | $3,286 | $173 |
| Gabapentin | 23 | $269 | $12 |
| Clonazepam | 11 | $126 | $11 |
| Escitalopram | 13 | $112 | $9 |
| Lorazepam | 20 | $85 | $4 |
2018: 1 drug
| Venlafaxine Hcl Er | 15 | $483 | $32 |
Money from drug and device companies
$49 in 2025
| 2025 | 2 | 2 | None | $49 |
| 2024 | 3 | 7 | None | $158 |
| 2023 | 1 | 4 | None | $127 |
| 2022 | 1 | 2 | None | $61 |
| 2020 | 1 | 2 | None | $53 |
| 2019 | 1 | 5 | None | $143 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Spravato | $34 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $15 | 1 payment
|
See all 2 published payments
| Janssen Pharmaceuticals | Meals · 2025-11-12 | Spravato | $34 |
| Supernus Pharmaceuticals | Meals · 2025-04-29 | Qelbree | $15 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $158
| Janssen Pharmaceuticals | Spravato | $101 | 4 payments
|
| Supernus Pharmaceuticals | Qelbree | $31 | 2 payments
|
| Janssen Scientific Affairs | Spravato | $26 | 1 payment
|
2023: $127
| Janssen Pharmaceuticals | Spravato | $127 | 4 payments
|
2022: $61
| Neuronetics | Neurostar Tms Therapy System | $61 | 2 payments
|
2020: $53
| Neuronetics | Neurostar Tms Therapy | $53 | 2 payments
|
2019: $143
| Neuronetics | Neurostar Tms Therapy | $143 | 5 payments
|
Professional record
- NPI
- 1225293293
- Licence
- CA A133513, OH 35.098282California A133513: Current · expires 2028-02-29
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 2150 E Bidwell St, Folsom, CA, 95630
- NPI first listed
- 2008-07-18
- NPI last updated
- 2020-09-02
- NPI record certified
- 2020-09-02
This is when the NPI record was last certified, not a medical board exam.